ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 9 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,349,000 | -53.7% | 12,254,080 | 0.0% | 0.01% | -59.1% |
| Q2 2020 | $2,915,000 | +25.4% | 12,254,080 | 0.0% | 0.02% | 0.0% |
| Q1 2020 | $2,325,000 | -41.8% | 12,254,080 | +1.5% | 0.02% | -29.0% |
| Q4 2019 | $3,996,000 | -11.0% | 12,073,080 | 0.0% | 0.03% | -20.5% |
| Q3 2019 | $4,489,000 | +61.6% | 12,073,080 | 0.0% | 0.04% | +50.0% |
| Q2 2019 | $2,778,000 | -34.3% | 12,073,080 | 0.0% | 0.03% | -35.0% |
| Q1 2019 | $4,226,000 | -71.5% | 12,073,080 | 0.0% | 0.04% | -75.6% |
| Q4 2018 | $14,850,000 | -34.3% | 12,073,080 | -0.0% | 0.16% | -24.1% |
| Q3 2018 | $22,588,000 | -16.9% | 12,079,080 | 0.0% | 0.22% | -24.7% |
| Q2 2018 | $27,178,000 | +6250.0% | 12,079,080 | +6107.1% | 0.29% | +5640.0% |
| Q1 2018 | $428,000 | +11.2% | 194,600 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $385,000 | – | 194,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 12,079,080 | $27,178,000 | 0.29% |
| jvl associates llc | 58,500 | $132,000 | 0.13% |
| Sigma Planning Corp | 27,500 | $62,000 | 0.00% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 280 | $1,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,158 | $9,000 | 0.00% |
| Ameritas Investment Partners, Inc. | 2,890 | $7,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 60,388 | $136,000 | 0.00% |
| UBS Group AG | 9,495 | $21,000 | 0.00% |
| RHUMBLINE ADVISERS | 31,685 | $71,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1,290 | $2,902,000 | 0.00% |